The record
Legislation· Sep 2026
Legislation· Sep 2026HR 10628 In House committee
Sponsored by Nicholas A. Langworthy (R)
Biosimilars Access and Affordability Act
To amend title XI of the Act to alter when biosimilar biological products are eligible for price negotiations under the .
What's in it
See official bill textHouse
Introduced
(Sep 28, 2026)
House
Committee on Energy and Commerce(Sep 28, 2026)
The bill went to more than one committee at the same time.
- Jake Auchincloss (D-MA)
- John Joyce (R-PA)
- Linda T. Sánchez (D-CA)
- Scott H. Peters (D-CA)
- Rudy Yakym (R-IN)
- Nathaniel Moran (R-TX)
- Kevin Mullin (D-CA)
- Jimmy Panetta (D-CA)
- Donald G. Davis (D-NC)
Recently introduced · no floor action yet